| Tcl1 expression in chronic lymphocytic leukemia is regulated by miR-29 and miR-181 Y Pekarsky, U Santanam, A Cimmino, A Palamarchuk, A Efanov, ... Cancer research 66 (24), 11590-11593, 2006 | 845 | 2006 |
| Functional association between Wwox tumor suppressor protein and p73, a p53 homolog RI Aqeilan, Y Pekarsky, JJ Herrero, A Palamarchuk, J Letofsky, T Druck, ... Proceedings of the National Academy of Sciences 101 (13), 4401-4406, 2004 | 296 | 2004 |
| NOTCH1 mutations in CLL associated with trisomy 12 V Balatti, A Bottoni, A Palamarchuk, H Alder, LZ Rassenti, TJ Kipps, ... Blood, The Journal of the American Society of Hematology 119 (2), 329-331, 2012 | 276 | 2012 |
| Chronic lymphocytic leukemia modeled in mouse by targeted miR-29 expression U Santanam, N Zanesi, A Efanov, S Costinean, A Palamarchuk, JP Hagan, ... Proceedings of the National Academy of Sciences 107 (27), 12210-12215, 2010 | 263 | 2010 |
| WW domain–containing proteins, WWOX and YAP, compete for interaction with ErbB-4 and modulate its transcriptional function RI Aqeilan, V Donati, A Palamarchuk, F Trapasso, M Kaou, Y Pekarsky, ... Cancer research 65 (15), 6764-6772, 2005 | 242 | 2005 |
| tsRNA signatures in cancer V Balatti, G Nigita, D Veneziano, A Drusco, GS Stein, TL Messier, ... Proceedings of the National Academy of Sciences 114 (30), 8071-8076, 2017 | 228 | 2017 |
| Akt phosphorylates and regulates the orphan nuclear receptor Nur77 Y Pekarsky, C Hallas, A Palamarchuk, A Koval, F Bullrich, Y Hirata, ... Proceedings of the National Academy of Sciences 98 (7), 3690-3694, 2001 | 225 | 2001 |
| Dysregulation of a family of short noncoding RNAs, tsRNAs, in human cancer Y Pekarsky, V Balatti, A Palamarchuk, L Rizzotto, D Veneziano, G Nigita, ... Proceedings of the National Academy of Sciences 113 (18), 5071-5076, 2016 | 214 | 2016 |
| FHIT: from gene discovery to cancer treatment and prevention Y Pekarsky, N Zanesi, A Palamarchuk, K Huebner, CM Croce The lancet oncology 3 (12), 748-754, 2002 | 199 | 2002 |
| Akt phosphorylates and regulates Pdcd4 tumor suppressor protein A Palamarchuk, A Efanov, V Maximov, RI Aqeilan, CM Croce, Y Pekarsky Cancer research 65 (24), 11282-11286, 2005 | 197 | 2005 |
| Physical and functional interactions between the Wwox tumor suppressor protein and the AP-2γ transcription factor RI Aqeilan, A Palamarchuk, RJ Weigel, JJ Herrero, Y Pekarsky, CM Croce Cancer research 64 (22), 8256-8261, 2004 | 195 | 2004 |
| Tcl1 functions as a transcriptional regulator and is directly involved in the pathogenesis of CLL Y Pekarsky, A Palamarchuk, V Maximov, A Efanov, N Nazaryan, ... Proceedings of the National Academy of Sciences 105 (50), 19643-19648, 2008 | 173 | 2008 |
| 13q14 deletions in CLL involve cooperating tumor suppressors A Palamarchuk, A Efanov, N Nazaryan, U Santanam, H Alder, L Rassenti, ... Blood, The Journal of the American Society of Hematology 115 (19), 3916-3922, 2010 | 126 | 2010 |
| Physical association with WWOX suppresses c-Jun transcriptional activity E Gaudio, A Palamarchuk, T Palumbo, F Trapasso, Y Pekarsky, CM Croce, ... Cancer research 66 (24), 11585-11589, 2006 | 108 | 2006 |
| Fhit is a physiological target of the protein kinase Src Y Pekarsky, PN Garrison, A Palamarchuk, N Zanesi, RI Aqeilan, ... Proceedings of the National Academy of Sciences 101 (11), 3775-3779, 2004 | 95 | 2004 |
| TCL1 targeting miR-3676 is codeleted with tumor protein p53 in chronic lymphocytic leukemia V Balatti, L Rizzotto, C Miller, A Palamarchuk, P Fadda, R Pandolfo, ... Proceedings of the National Academy of Sciences 112 (7), 2169-2174, 2015 | 79 | 2015 |
| Tcl1 protein functions as an inhibitor of de novo DNA methylation in B-cell chronic lymphocytic leukemia (CLL) A Palamarchuk, PS Yan, N Zanesi, L Wang, B Rodrigues, M Murphy, ... Proceedings of the National Academy of Sciences 109 (7), 2555-2560, 2012 | 73 | 2012 |
| IRF4 mutations in chronic lymphocytic leukemia V Havelange, Y Pekarsky, T Nakamura, A Palamarchuk, H Alder, ... Blood, The Journal of the American Society of Hematology 118 (10), 2827-2829, 2011 | 68 | 2011 |
| Tcl1 interacts with Atm and enhances NF-κB activation in hematologic malignancies E Gaudio, R Spizzo, F Paduano, Z Luo, A Efanov, A Palamarchuk, ... Blood, The Journal of the American Society of Hematology 119 (1), 180-187, 2012 | 65 | 2012 |
| FHIT as Tumor Suppressor: Mechanisms and Therapeutic Opportunities Y Pekarsky, A Palamarchuk, K Huebner, CM Croce Cancer Biology & Therapy 1 (3), 232-236, 2002 | 65 | 2002 |
